Topics

Articles

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today. 

Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report. 

A panel examines the gross-to-net bubble across various product mixes, how pricing impacts market access, and more.  

Kevin O’Meara discusses how patient service teams influence adherence from Direct-to-Patient models. 

Kevin O’Meara discusses Patient-Cetric 3.0 breakout session and the challenges of drug manufactures implementing Direct-to-Patient models.

Breakout session explores how direct-to-patient models shorten the time to diagnosis and therapy to improve patient outcomes.

Access Insights Conference delves into the latest obstacles,   while mapping out potential solutions to address them. 

A cohort study of cancer drugs analyzes where the priorities of pricing policies should lie.

Is the potential of a more formal policy integration for health issues and disease prevention a scary suggestion or a good Idea?